Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chen Amy Shaw-Ru"'
Autor:
Chen Amy Shaw-Ru, Anup Madan, Janet Sim, Ons Harrabi, Tracy C. Kuo, Hong Wan, Ardian S Wibowo, Shelley Izquierdo, Emma Sangalang, Darlene Pedersen, Josh Carter, Steven E. Kauder, Jonathan T. Sockolosky, Jaume Pons, Harriman William Don, Laura Doyle
Publikováno v:
mAbs
Targeting the CD47-signal-regulatory protein α (SIRPα) pathway represents a novel therapeutic approach to enhance anti-cancer immunity by promoting both innate and adaptive immune responses. Unlike CD47, which is expressed ubiquitously, SIRPα expr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66b6e62d7e10586ce646d15c3a63cebd
http://europepmc.org/articles/PMC6748616
http://europepmc.org/articles/PMC6748616
Autor:
Trevor Bentley, Janette Sutton, Julien Valton, Colleen Brown, Holly Dong, Thomas Pertel, Chen Amy Shaw-Ru, Philippe Duchateau, Javier Chaparro-Riggers, Tracy C. Kuo, Cesar Sommer, Roman Galetto, Tao Sai, Bijan Boldajipour, Thomas Van Blarcom, Tao Geng, Julianne Smith, Alexandre Juillerat, Pascua Edward Derrick, Sherman M. Chin, Arvind Rajpal, Yajin Ni, Barbra Sasu, Annabelle Gariboldi
Publikováno v:
Mol Ther
Clinical success of autologous CD19-directed chimeric antigen receptor T cells (CAR Ts) in acute lymphoblastic leukemia and non-Hodgkin lymphoma suggests that CAR Ts may be a promising therapy for hematological malignancies, including multiple myelom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7250acc3b33bf3bef5ebe0e7aa4d80a
https://europepmc.org/articles/PMC6554542/
https://europepmc.org/articles/PMC6554542/
Autor:
Cris Kamperschroer, Laura Aschenbrenner, Kevin Lindquist, David L. Shelton, Pascua Edward Derrick, Wei Chen, Pavel Strop, Tracy C. Kuo, Chen Amy Shaw-Ru, Yik Andy Yeung, Jeffrey L. Wolf, Barbra Sasu, Michael Mirsky, Thomas Van Blarcom, Ingrid D. Pardo, Santiago E. Farias, Bing Kuang, Tao Geng, Javier Chaparro-Riggers, Siler Panowski, Bora Han, Marjorie Bateman, Allison Given Chunyk, Russell Dushin, Sherman M. Chin, Kathy Delaria, Yi Zhang, Arvind Rajpal, Thomas G. Martin, Bernard S. Buetow
Publikováno v:
Molecular cancer therapeutics. 18(11)
The restricted expression pattern of B-cell maturation antigen (BCMA) makes it an ideal tumor-associated antigen (TAA) for the treatment of myeloma. BCMA has been targeted by both CD3 bispecific antibody and antibody–drug conjugate (ADC) modalities
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fa0945fc5a4fe1b6472aa5ea3f6ea56
https://pubmed.ncbi.nlm.nih.gov/31434693
https://pubmed.ncbi.nlm.nih.gov/31434693
Autor:
Hong H Dong, Roman Galetto, Tracy C. Kuo, Thomas Van Blarcom, Yoon Park, Chen Amy Shaw-Ru, Javier Chaparro-Riggers, Arvind Rajpal, Tao Geng, Barbra Sasu, Bijan Boldajipour, Julianne Smith, Gregory R Boucher, Annabelle Gariboldi, Thomas Pertel, Julien Valton, Cesar Sommer
Publikováno v:
Blood. 128:381-381
Multiple myeloma (MM) is a hematological disease of plasma B cells that remains incurable despite the availability of numerous therapies. The plasma cell-specific expression of the TNF superfamily receptor BCMA may allow targeting of normal and malig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67741673a190bb3b91f3a989678aef7a
https://doi.org/10.1182/blood.v128.22.381.381
https://doi.org/10.1182/blood.v128.22.381.381